RiboseAG™ - NR Cellular Energy plus Telomere Growth Factor


UltraHealth's RiboseAG™ uses both pharmaceutical grade RiboGEN™ and Cycloastragenol which is unique in that it provides cells energy, increases NAD+, and helps lengthen the body's telomeres.  RiboGEN™ (proprietary / 99.5% nicotinamide riboside) enhances Cycloastragenol's ability to work.

What is Cycloastragenol and how does it improve our DNA replication? Cycloastragenol is a very rare plant-based compound, which can help maintain or rebuild parts of the cells, called telomeres, that diminish as people get older and play a major role in the cellular aging process. A telomere is a repeating DNA sequence (for example, TTAGGG) at the end of the body's chromosomes. The telomere can reach a length of 15,000 base pairs. Telomeres function by preventing chromosomes from losing base pair sequences at their ends. They also stop chromosomes from fusing to each other.

Telomere length shortens with age. Progressive shortening of telomeres leads to senescence, apoptosis, or oncogenic transformation of somatic cells, affecting the health and lifespan of an individual. Shorter telomeres have been associated with increased incidence of diseases and protect chromosomal ends from fusion and degradation.

Tel Aviv University and The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center announced in 2020, for the first time in humans, two key biological hallmarks of aging, telomere length shortening and accumulation of senescent cells, can be reversed.

 UltraHealth's proprietary synthesis of both RiboGEN™ and Cycloastragenol activates telomerase which lengthens telomeres and allows your body to product younger undamaged DNA. UltraHealth's synthesized Cycloastragenol is a complete match for the extract of the genus Astragalus that has telomerase activation qualities. A preliminary in vitro study on human CD4 and CD8 T cells found that cycloastragenol increased telomerase activity and inhibit the onset of cellular senescence.

You may also like

Recently viewed